ASSOCIATIONS BETWEEN ORAL CLEFTS AND DRUGS TAKEN DURING PREGNANCY

[1] BEVELANDER G, 1962, BIOL NEONATORUM, V4, P365

[2] BROWN DM, 1968, TOXICOL APPL PHARM, V12, P295

[3] Cahen R L, 1966, Adv Pharmacol, V4, P263, DOI 10.1016/S1054-3589(08)60101-5

[4] CARTER MP, 1965, DEV MED CHILD NEUROL, V7, P353

[5] CLAVERT J, 1963, CR SOC BIOL, V157, P1481

[6] TERATOGENIC DRUGS - RCGP SURVEY [J]. BRITISH MEDICAL JOURNAL, 1970, 4 (5728) : 178 - &

[7] Degenhardt K H, 1972, Adv Exp Med Biol, V27, P467

[8] Elshove J, 1971, Ned Tijdschr Geneeskd, V115, P1371

[9] FARKAS L G, 1970, Acta Chirurgiae Plasticae, V12, P29

[10] FILIPPI B, 1967, ADV TERATOL, V2, P239

[1] BEVELANDER G, 1962, BIOL NEONATORUM, V4, P365

[2] BROWN DM, 1968, TOXICOL APPL PHARM, V12, P295

[3] Cahen R L, 1966, Adv Pharmacol, V4, P263, DOI 10.1016/S1054-3589(08)60101-5

[4] CARTER MP, 1965, DEV MED CHILD NEUROL, V7, P353

[5] CLAVERT J, 1963, CR SOC BIOL, V157, P1481

[6] TERATOGENIC DRUGS - RCGP SURVEY [J]. BRITISH MEDICAL JOURNAL, 1970, 4 (5728) : 178 - &

[7] Degenhardt K H, 1972, Adv Exp Med Biol, V27, P467

[8] Elshove J, 1971, Ned Tijdschr Geneeskd, V115, P1371

[9] FARKAS L G, 1970, Acta Chirurgiae Plasticae, V12, P29

[10] FILIPPI B, 1967, ADV TERATOL, V2, P239